Cargando…
The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect
PURPOSE: Growth hormone transduction defect (GHTD) is characterized by severe short stature, impaired STAT3 (signal transducer and activator of transcription-3) phosphorylation and overexpression of the cytokine inducible SH2 containing protein (CIS) and p21/CIP1/WAF1. To investigate the role of p21...
Autores principales: | Kostopoulou, Eirini, Rojas Gil, Andrea Paola, Spiliotis, Bessie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Pediatric Endocrinology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312915/ https://www.ncbi.nlm.nih.gov/pubmed/30599481 http://dx.doi.org/10.6065/apem.2018.23.4.204 |
Ejemplares similares
-
Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition
Publicado: (1995) -
Recombinant human growth hormone in the treatment of Turner syndrome
por: Spiliotis, Bessie E
Publicado: (2008) -
In vivo effect of an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors
por: Flores, Ana Isabel, et al.
Publicado: (2009) -
p300 Alters Keratinocyte Cell Growth and Differentiation through Regulation of p21(Waf1/CIP1)
por: Wong, Ping-Pui, et al.
Publicado: (2010) -
Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism
por: Paydas, Saime, et al.
Publicado: (2014)